deltatrials
Terminated NA INTERVENTIONAL 2-arm NCT00521885

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients (BRiEF)

Arixtra(Fondaparinux) vs. Lovenox (Enoxaparin) in Prevention of DVT in Acute Medically Ill, Non-surgical Patients

Sponsor: GlaxoSmithKline

Conditions Venous Thrombosis
Interventions Arixtra (Fondaparinox) 2.5 mg SC Daily Lovenox 40mg SC Daily
Updated 13 times since 2017 Last updated: Oct 14, 2021 Started: Sep 30, 2007 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study stopped due to lack of accrual

Other terminated trials from GlaxoSmithKline

See all terminations from GlaxoSmithKline

Other Venous Thrombosis trials with similar outcome

Browse all Venous Thrombosis trials

Listed as NCT00521885, this NA trial focuses on Venous Thrombosis and remains terminated or withdrawn. Sponsored by GlaxoSmithKline, it has been updated 13 times since 2007, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Nov 2017 · 2 months · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshot~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated NA

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

  5. Dec 2021 — Dec 2022 [monthly]

    Terminated NA

▶ Show 8 earlier versions

  1. Nov 2021 — Dec 2021 [monthly]

    Terminated NA

  2. Jan 2021 — Nov 2021 [monthly]

    Terminated NA

  3. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  4. Dec 2017 — Jun 2018 [monthly]

    Terminated NA

  5. Nov 2017 — Dec 2017 [monthly]

    Terminated NA

  6. Sep 2017 — Nov 2017 [monthly]

    Terminated NA

  7. Feb 2017 — Sep 2017 [monthly]

    Terminated NA

  8. Jan 2017 — Feb 2017 [monthly]

    Terminated NA

    First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
  • Lehigh Valley Hospital
Data source: Lehigh Valley Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations